BioCentury
ARTICLE | Company News

Takeda divesting $10B in non-core assets following completed Shire acquisition

January 11, 2019 6:12 PM UTC

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said Jan. 7 that it completed its acquisition of Shire plc (Dublin, Ireland).

At the J.P. Morgan Healthcare Conference on Jan. 8 to discuss the acquisition, Takeda President and CEO Christophe Weber said the company will sell its "non-core assets" for $10 billion. He said the company has identified the divestitures and engaged with buyers, but did not disclose details...